Janux Therapeutics Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, Janux Therapeutics stock has a consensus rating of "Buy" and an average price target of $37.19. The average 1-year stock price forecast is 126.77% higher than the current stock price, while the lowest is $14 (-14.63%) and the highest is $72 (+339.02%).

Price Target: $37.19 (+126.77%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$14	$37.19	$32.5	$72
Change	-14.63%	+126.77%	+98.17%	+339.02%

Analyst Ratings

The average analyst rating for Janux Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	15	14	14	13	13	13
Buy	3	3	3	2	2	2
Hold	1	1	1	2	2	2
Sell	0	0	0	1	1	1
Strong Sell	0	0	0	0	0	0
Total	19	18	18	18	18	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Supawat Thongthip Truist Financial	Truist Financial	Buy Initiates $80 → $26	Buy	Initiates	$80 → $26	+58.54%	Jun 25, 2026
Jonathan Miller Evercore ISI	Evercore ISI	Buy Maintains $23 → $22	Buy	Maintains	$23 → $22	+34.15%	May 11, 2026
Swayampakula Ramakanth H.C. Wainwright	H.C. Wainwright	Buy Reiterates $45	Buy	Reiterates	$45	+174.39%	May 11, 2026
Oliver McCammon LifeSci Capital	LifeSci Capital	Buy Reiterates $60	Buy	Reiterates	$60	+265.85%	May 8, 2026
Robert Driscoll Wedbush	Wedbush	Buy Reiterates $45 → $36	Buy	Reiterates	$45 → $36	+119.51%	May 8, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

31.59M

from 10.00M

215.94%

from 10.00M

Revenue Next Year

6.95M

from 31.59M

-78.00%

from 31.59M

EPS This Year

-1.76

from -1.83

EPS Next Year

-2.70

from -1.76

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	3.64M	8.61M	8.08M	10.59M	10.00M	31.59M
Revenue Growth	-	136.79%	-6.14%	30.99%	-5.55%	215.94%
Operating Income	-32.93M	-67.09M	-72.98M	-98.85M	-157.67M	-140.62M
Net Income	-32.67M	-63.06M	-58.29M	-68.99M	-113.63M	-103.97M
EPS	-	-	-	-	-1.83	-1.76
Free Cash Flow	577.38K	-30.56M	-29.52M	-26.14M	-51.27M	-143.90M
No. Analysts	-	-	-	-	-	14

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	68.2M
Avg	31.6M
Low	3.7M

Revenue Growth

Revenue Growth	2026	2027	2028
High	581.6%
Avg	215.9%
Low	-63.0%

EPS Forecast

EPS	2026	2027	2028
High	-0.81
Avg	-1.76
Low	-2.54

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-